KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Tax Provisions (2021 - 2025)

Novavax has reported Tax Provisions over the past 8 years, most recently at $376000.0 for Q4 2025.

  • Quarterly results put Tax Provisions at $376000.0 for Q4 2025, down 94.95% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (down 82.86% YoY), and the annual figure for FY2025 was $1.9 million, down 82.86%.
  • Tax Provisions for Q4 2025 was $376000.0 at Novavax, up from -$657000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for NVAX hit a ceiling of $16.6 million in Q4 2021 and a floor of -$2.3 million in Q4 2022.
  • Median Tax Provisions over the past 5 years was $1.6 million (2022), compared with a mean of $2.4 million.
  • Biggest five-year swings in Tax Provisions: crashed 128.2% in 2023 and later surged 1641.96% in 2024.
  • Novavax's Tax Provisions stood at $16.6 million in 2021, then plummeted by 113.61% to -$2.3 million in 2022, then skyrocketed by 174.69% to $1.7 million in 2023, then soared by 341.29% to $7.4 million in 2024, then plummeted by 94.95% to $376000.0 in 2025.
  • The last three reported values for Tax Provisions were $376000.0 (Q4 2025), -$657000.0 (Q3 2025), and $946000.0 (Q2 2025) per Business Quant data.